Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
TransAct Technologies Incorporated is a computer hardware business based in the US. TransAct Technologies Incorporated shares (TACT) are listed on the NASDAQ and all prices are listed in US Dollars. TransAct Technologies Incorporated employs 118 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $4.00 |
|---|---|
| 52-week range | $3.86 - $17.18 |
| 50-day moving average | $4.92 |
| 200-day moving average | $9.19 |
| Wall St. target price | $10.94 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.63 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $4 from 2022-07-01
| 1 week (2022-06-24) | -3.61% |
|---|---|
| 1 month (2022-06-03) | -10.11% |
| 3 months (2022-04-01) | -44.44% |
| 6 months (2022-01-03) | -62.89% |
| 1 year (2021-07-02) | -70.44% |
|---|---|
| 2 years (2020-07-02) | -11.31% |
| 3 years (2019-07-03) | 11.59 |
| 5 years (2017-07-03) | 8.55 |
Valuing TransAct Technologies Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of TransAct Technologies Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
TransAct Technologies Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.91. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into TransAct Technologies Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $40.8 million |
|---|---|
| Gross profit TTM | $15.2 million |
| Return on assets TTM | -17.54% |
| Return on equity TTM | -18.75% |
| Profit margin | -14.59% |
| Book value | $3.54 |
| Market capitalisation | $39.9 million |
TTM: trailing 12 months
We're not expecting TransAct Technologies Incorporated to pay a dividend over the next 12 months.
TransAct Technologies Incorporated's shares were split on a 3:2 basis on 4 April 2004. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your TransAct Technologies Incorporated shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for TransAct Technologies Incorporated shares which in turn could have impacted TransAct Technologies Incorporated's share price.
Over the last 12 months, TransAct Technologies Incorporated's shares have ranged in value from as little as $3.86 up to $17.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TransAct Technologies Incorporated's is 1.8852. This would suggest that TransAct Technologies Incorporated's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
TransAct Technologies Incorporated designs, develops, and markets transaction-based and specialty printers and terminals in the United States and internationally. Its thermal printers and terminals to generates labels, coupons, and transaction records, such as receipts, tickets, and other documents, as well as printed logging and plotting of data. The company also provides consumable products, including POS receipt paper, inkjet cartridges, ribbons, and other printing supplies, as well as replacement parts and accessories; maintenance and repair services; and refurbished printers. In addition, it offers EPICENTRAL print system, a software solution that enables casino operators to create promotional coupons and marketing messages, and print them at the slot machine; and technical support services, as well as spare parts and accessories. Further, the company provides BOHA! terminal that combines hardware and software components in a device that includes an operating system, touchscreen, and one or two thermal print mechanisms. It markets its products under the BOHA!, AccuDate, Epic, Ithaca, EPICENTRAL, and Printrex brands for food service technology, point of sale automation, casino and gaming, lottery, and oil and gas markets, as well as government. The company sells its products to original equipment manufacturers, value-added resellers, and distributors, as well as directly to end-users through its Webstore transactsupplies.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.